Researchers at Wake Forest Baptist Medical Center have modified electrically conductive polymers, commonly used in solar energy applications, to develop revolutionary polymer nanoparticles (PNs) for a medical application. When the nanoparticles are
Called BRIGHTs, the tiny probes described in the online issue of Advanced Materials on Nov. 15, bind to biomarkers of disease and, when swept by an infrared laser, light up to reveal their location.
Health professionals may soon have a new method of diagnosing Parkinson's disease, one that is noninvasive and inexpensive, and, in early testing, has proved to be effective more than 90 percent of the time.
Electroconvulsive therapy (ECT) is considered the most effective treatment option for patients with severe depression who cannot find symptom relief through antidepressant medications or psychotherapy. In a new study, researchers at Butler Hospital and
Alzheimer's therapeutic trials have gotten bad press lately, but it is not all gloom and doom. As evident at the 5th Clinical Trials in Alzheimer's Disease (CTAD) conference, held 29-31 October in the Principality of Monaco, scientists keep extracting
By . S.-Y. Lee, R. Burdeinick-Kerr, S. P. J. Whelan
Viruses can be elusive quarry. RNA viruses are particularly adept at defeating antiviral drugs because they are so inaccurate in making copies of themselves. With at least one error in every genome they copy, viral genomes are moving targets for antivi
A medical researcher with the University of Alberta and his team just published their findings about their work on developing 'homing beacon drugs' that kill only cancer cells, not healthy ones, thanks to nano-technology.
An international multi-disciplinary research team led by Northwestern Medicine scientists has uncovered a new role for the protein toll-like receptor 4 (TLR4) in the development of tissue fibrosis, or scarring.
New insights into what causes uncontrollable bleeding in hemophilia patients are provided in a study published by Cell Press on November 20th in the Biophysical Journal. By revealing that blood clots spread in traveling waves through vessels, the study
If you are among the 50 percent of Americans who suffer from insomnia, then you have probably tried everything -- from warm milk to melatonin pills or prescription medications to induce sleep -- with varying degrees of success and side effects. But wha
Antibiotic resistance results from bacteria's uncanny ability to morph and adapt, outwitting pharmaceuticals that are supposed to kill them. But exactly how the bacteria acquire and spread that resistance inside individuals carrying them is not well-es
By Wolters Kluwer Health: Lippincott Williams & Wilkins
Meningiomas are a common type of benign brain tumor that sometimes grows dramatically in pregnant women. A new study suggests that this sudden tumor growth likely results from "hemodynamic changes" associated with pregnancy, reports the Novem
Teens who participate in after-school arts activities such as music, drama and painting are more likely to report feeling depressed or sad than students who are not involved in these programs, according to new research published by the American Psychol
By Substance Abuse and Mental Health Administration
More than a quarter of the American population who are too young to drink are doing so anyway according to a new report issued November 23 by the Substance Abuse and Mental Health Services Administration (SAMHSA).
Gastric bypass patients who attended five follow-up office visits in two years as recommended by their surgeons lost nearly twice as much weight (113 lbs. vs. 57 lbs.) as patients who attended only two follow-up visits, according to a University of Pen
The discovery of the molecular pathway that drives the changes seen in the brains of Alzheimer's patients is reported November 20, revealing new targets for drug discovery that could be exploited to combat the disease. The study gives the most de
In a world-first, researchers from the Australian Centre for Nanomedicine at the University of New South Wales (UNSW) in Sydney have developed a nanoparticle that could improve the effectiveness of chemotherapy for neuroblastoma by a factor of five.
Researchers from John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's 50 best cancer centers, played an important role in a study published in the New England Journal of Medicine on October 18 that may change the curr
